Plymouth Meeting, Pa.-based nonprofit organization, the Emergency Care Research Institute, has released its 2023 list of health systems demonstrating excellence on their end of the medical supply chain.
Supply Chain
The FDA labeled 22,769 Baxter drug infusion devices as a Class I recall after receiving reports of false upstream occlusion alarms, which can delay therapy.
After four patient deaths, Abiomed clarified to customers of its Impella Left Sided Blood Pumps that the device could break a distal stent's blade in transcatheter aortic valve replacement patients.
Abbott recalled 672 cardiac catheters because of an increased risk of air bubbles, which can affect a patient's heartbeat and blood pressure, the FDA said July 26.
Ansell is proud to introduce the Sustainable Manufacturing Podcast, where thought leaders in the healthcare industry explore the latest innovations in ecofriendly business models and solutions.
Advertisement
The tornado that ripped through a Pfizer plant in Rocky Mount, N.C., mainly damaged its warehouse and missed the manufacturing side, the drugmaker said July 21.
Medline Industries, a private manufacturer and distributor of medical products, is now home to New York's largest rooftop solar project at its Montgomery distribution center, according to a July 20 news release.
Supply chain plays a critical part in hospital operations, and the same goes for the people in charge of supply chain.
Medical devicemaker Getinge saw its core profit reduce by half in its second quarter as quality and supply problems "overshadowed" monetary growth, the company said July 18.
Medtronic recalled 348,616 implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators because they might fail to deliver energy when high voltage therapy is needed, the FDA said July 18.